The US Food and Drug Administration (FDA) recently included four cosmetic-related recalls in its Enforcement Report. All recalls were voluntarily initiated by the respective companies and remain ongoing. The cases highlight two persistent compliance concerns in the cosmetics sector: the presence of prohibited substances and microbial contamination.
One of the recalls involved a nail polish remover kit after FDA testing identified methylene chloride and chloroform in the product. Both substances are prohibited for use in cosmetics under US regulations, which led to a Class II recall classification.
Two additional recalls concerned unscented and cucumber-scented baby wipes. The products were recalled due to potential contamination with Burkholderia cepacia complex and Burkholderia gladioli. FDA classified these actions as Class I recalls, indicating a risk of serious adverse health consequences associated with product use.
The fourth recall involved Oribe Serene Scalp Densifying Shampoo, which was found to be contaminated with the microorganism Pluralibacter gergoviae. The affected product was categorized under a Class II recall.
These cases serve as a reminder that both formulation compliance and microbiological quality management remain critical for products marketed in the United States. Manufacturers are encouraged to routinely review formulations for compliance with ingredient restrictions, strengthen preservation systems, implement effective environmental controls during production, and monitor regulatory safety alerts across major markets.